
References for "Research suggests new drug targets for depression"
NOV 2010
Did you know?
You can get instant online access to all of the articles from the November 2010 issue of Harvard Mental Health Letter for only $5.
Already a subscriber? Login for complete instant access.
Berman RM, et al. “Antidepressant Effects of Ketamine in Depressed Patients,” Biological Psychiatry (Feb. 15, 2000): Vol. 47, No. 4, pp. 351–54. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10686270
Diazgranados N, et al. “A Randomized Add-On Trial of an N-Methyl-D-Aspartate Antagonist in Treatment-Resistant Bipolar Depression,” Archives of General Psychiatry (Aug. 2010): Vol. 67, No. 8, pp. 793–802. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20679587
Krystal JH. “Ketamine and the Potential Role for Rapid-Acting Antidepressant Medications,” Swiss Medical Weekly (April 21, 2007): Vol. 137, No. 15–16, pp. 215–16. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17525875
Li N, et al. “mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists,” Science (Aug. 20, 2010): Vol. 329, No. 5994, pp. 959–964. www.ncbi.nlm.nih.gov/pubmed/20724638
Zarate CA, Jr., et al. “A Randomized Trial of an N-Methyl-D-Aspartate Antagonist in Treatment-Resistant Major Depression,” Archives of General Psychiatry (Aug. 2006): Vol. 63, No. 8, pp. 856–64. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16894061
